. 2009 Jul;3(2):177–186.

Table (2).

Serum fasting glucose; fasting insulin (pmol/l) and HOMA-IR of the studied groups (CHC with elevated enzymes; CHC witn normal enzymes versus normal healthy control).

	FBG (mmol/l)	FI (μU/l)	HOMA-IR	Fibrosis
	FBG (mmol/l)	FI (μU/l)	HOMA-IR	+ve	−ve

Group -1 CHC with elevated enzymes	4.9±0.75 a	17.85±4.5ac	3.98±1.41ac	21	2

Group -2 CHC with normal enzymes	4.6±0.51	12.68±2.5b	2.69±0.76	13	2

Group -3 Healthy Control	4.1±0.42	9.1±3.6	1.92±0.74

Group -1 versus Group -3	P=0.05^*	P<0.001^**	P<0.001^**

Group -2 versus Group -3	P=0.112	P<0.001^**	P=0.071

Group -1 versus Group -2	P=0.071	P=0.009^**	P=0.09^**	P=0.023^*

Comparison between the different groups by using ANOVA test for numerical data and Chi square test for percentages.

P: mildly statistically significant (P<0.05).

^**

P: highly statistically significant (P<0.01). F=6.21 = p < 0.001**.

^{a :}

Group1 versus Group3.

^{b :}

Group2 versus Group3.

^{c :}

Group1 versus Group2. %: Percentage. NS: non-significant. CHC: chronic hepatitis C virus. FBG: Fasting blood glucose. FI: Fasting insulin. HOMA-IR: Homeostasis model assessment-Insulin resistance.